Non-animal procedures, including in vitro test systems and test strategies, can already make a significant contribution to the background to risk assessment — in predicting both the toxic potential and toxic potency of chemicals, as well as, in some circumstances, the toxic hazard they may represent under specified conditions of exposure. They can be particularly useful for investigating molecular and cellular mechanisms of chemical-induced toxicity, and for identifying species-specific effects, which greatly limit the value of data from laboratory animal studies in the human risk assessment process. Attention is focused on the need for greater effort to be invested in the development of non-animal procedures for evaluating the biokinetic factors which will determine the ultimate form and concentration of a particular chemical at possible sites of toxic action. The relative merits of correlative and mechanistic approaches to test development and test validation are discussed. The need for realism is emphasised, not only in relation to our expectations of the validation process, but also in terms of the current and future status of regulatory toxicology, in vitro or in vivo, as a scientific discipline. Finally, it is concluded that the intelligent and strategic use of in vitro test systems, in conjunction with predictive computer modelling, could markedly improve the scientific basis of human risk assessment.
FlintO.P. (1992). In vitro test validation: a house built on sand.ATLA20, 196–198.
2.
Anon. (1991). Animals and alternatives in toxicology: present status and future prospects 1The Second Report of the FRAME Toxicity Committee).ATLA19, 116–138.
3.
BallsM., BlaauboerB., BrusickD., FrazierJ., LambD., PembertonM., ReinhardtC, RoberfroidM., RosenkranzH., SchmidB., SpielmannH., StammatiA-L., & WalumE. (1990). Report and recommendations of the CAAT/ ERGATT workshop on the validation of toxicity test procedures.ATLA18, 313–337.
4.
BallsM., BothamP., CordierA., FumeroS., KayserD., KoëterH., KoundakjianP., Gunnar LindquistN., MeyerO., PiodaL., ReinhardtC, RozemondH., SmyrniotisT., SpielmannH., Van LooyH., van der VenneM-T., & WalumE. (1990). Report and recommendations of an international workshop on promotion of the regulatory acceptance of validated non-animal toxicity test procedures.ATLA18, 339–344.
5.
PurchaseI.F.H. (1988). Carcinogenic risk assessment using animal data: the importance of mechanisms of toxic action. In Risk Assessment of Chemicals in the Environment (ed. RichardsonM.L.), pp. 177–191. London: Royal Society of Chemistry.
6.
CrumpK.S. (1984). A new method for determining allowable daily intakes.Fundamental and Applied Toxicology4, 854–871.
7.
BachP.H., CockburnA., EsdaileD.J., GrassoP., and LumleyC.E. (1991). Chronic toxicity testing: present perspectives and the way toward shorter screening, decreased use of resources and better risk assessment. In Animals and Alternatives in Toxicology: Present Status and Future Prospects (ed. BallsM., BridgesJ., SoutheeJ.), pp. 53–89. London: Macmillan and New York: VCH Publishers.
8.
McLeanA. (1991). Concluding remarks. In Animals and Alternatives in Toxicology: Present Status and Future Prospects (ed. BallsM., BridgesJ., SoutheeJ.), pp. 341–344. London: Macmillan and New York: VCH Publishers.
9.
WalumE., StenbergK., and JenssenD. (1990). Understanding Cell Toxicology: Principles and Practice, 206 pp. Chichester: Ellis Horwood.
10.
BallsM. (1986). Replacing experiments on laboratory animals.Trends in Biochemical Sciences11, 236–238.
11.
BallsM., GarleM., and ClothierR. (1991). Further developments in in vitro methodology.In Animals and Alternatives in Toxicology: Present Status and Future Prospects (ed. BallsM., BridgesJ., SoutheeJ.), pp. 313–339. London: Macmillan and New York: VCH Publishers.
12.
CookJ.R., GabrielsJ., PatroneL.M., RhoadsL.S., & Van BuskirkR.G. (1992). A human epidermal model that can be used in an automated multiple endpoint assay.ATLA20, 313–323.
13.
Hazen-MartinD.J., SensM.A., DetrisacC.J., BlackburnJ.G., and SensD.A. (1989). Elevated glucose alters paracellular transport of cultured human proximal tubule cells.Kidney International35, 31–39.
14.
AudusK.L., BartelR.L., HidalgoI.J., and BorchardtR.T. (1990). The use of cultured epithelial and endothelial cells for drug transport and metabolism studies.Pharmaceutical Research7, 435–451.
15.
FlintO.P. (1988). In vitro toxicology: a commercial proposition?Xenobiotica18, 707–714.
16.
FlintO.P. (1990). In vitro toxicity testing: purpose, validation and strategy.ATLA18, 11–18.
17.
FlintO.P. (1991). How soon can we expect in vitro tests to replace animal studies?Alternatives (Bristol-Myers Squibb)1, 3–6.
18.
EkwallB., and EkwallK. (1988). Comments on the use of diverse cell systems in toxicity testing.ATLA15, 193–201.
19.
EkwallB. (1992). Basal cytotoxicity data (BC-data) in human risk assessment. In Proceedings of the Workshop on Risk Assessment and Risk Management of Toxic Chemicals (ed. MiuraT., SomaY., TohyamaC.), pp. 137–142. Ibaraki, Japan: National Institute for Environmental Studies.
20.
FryJ., GarleM., and HammondA. (1988). Choice of acute toxicity measure for comparison of in vivo/in vitro toxicity.ATLA16, 175–179.
21.
ClothierR.H., HulmeL.M., SmithM., and BallsM. (1987). Comparison of the in vitro cytotoxicities and acute in vivo toxicities of 59 chemicals.Molecular Toxicology1, 571–577.
22.
HulmeL.M., ReevesH.L., ClothierR.H., SmithM., and BallsM. (1987). Assessment of two alternative methods for predicting the in vivo toxicities of metallic compounds.Molecular Toxicology1, 589–596.
23.
HalleW., and SpielmannH. (1992). Two procedures for the prediction of acute toxicity (LD50) from cytotoxicity data.ATLA20, 40–49.
24.
BracherM., FallerC., SpenglerJ., and ReinhardtC.A. (1989). Comparison of in vitro cell toxicity with in vivo eye irritation.Molecular Toxicology1, 561–570.
25.
WilcoxD.K., and BrunerL.H. (1990). In vitro alternatives for ocular safety testing: an outline of assays and possible future developments.ATLA18, 117–128.
26.
MarinovichM., TragniE., CorsiniA., and GalliC. (1990). Quantification of in vitro cytotoxicity of surfactants: correlation with their eye irritant potential.Journal of Toxicology — Cutaneous and Ocular Toxicology9, 169–178.
27.
BallsM., ReaderS., AtkinsonK., TarrantJ., and ClothierR. (1991). Non-animal alternative toxicity tests for detergents: genuine replacements or mere prescreens?Journal of Chemical Technology and Biotechnology50, 423–433.
28.
GadS.C. (1989). Acute ocular irritation evaluation: in vivo and in vitro alternatives and making them the “standard” for testing. In Benchmarks: Alternative Methods in Toxicology (ed. MehlmanM.A.), pp. 137–192. Princeton, NJ: Princeton Scientific.
29.
FrazierJ.M. (1991). Alternatives to acute ocular and dermal toxicity tests in animals. In Dermatotoxicology, 4th edn (ed. MarzulliF.N., MaibachH.I.), pp. 817–833. New York & London: Hemisphere Publishing.
30.
BallsM., AtkinsonK.A., and GordonV.C. (1991). Complementation in the development, validation and use of non-animal test batteries, with particular reference to ocular irritancy.ATLA19, 429–431.
31.
FielderR.J., GauntI.F., RhodesC., SullivanF.M., and SwanstonD.W. (1987). Hierarchical approach to the assessment of dermal and ocular irritancy: a report by the British Toxicology Society Working Party on irritancy.Human Toxicology6, 269–278.
32.
GordonV.C., and BergmanH.C. (1987). EYTEX™: an in vitro method for evaluation of ocular irritancy. In Alternative Methods in Toxicology, Vol. 5, Approaches to Validation (ed. GoldbergA.M.), pp. 293–302. New York: Mary Ann Liebert.
33.
ReaderS.J., BlackwellV., O'HaraR., ClothierR.H., and BallsM. (1989). A vital dye release method for assessing the short-term cytotoxic effects of chemicals and formulations.ATLA17, 28–33.
34.
ShawA.J., ClothierR.H., and BallsM. (1990). Loss of trans-epithelial impermeability of a confluent monolayer of Madin-Darby canine kidney cells as a determinant of ocular irritancy potential.ATLA18, 145–151.
35.
BorenfreundE., and PuernerJ.A. (1984). A simple quantitative procedure using monolayer cultures for cytotoxicity assays (HTD/NR90).Journal of Tissue Culture Methods9, 7–10.
36.
KnoxP., UphillP.F., FryJ.R., BenfordD.J., and BallsM. (1986). The FRAME multicentre project on in vitro cytotoxicology.Food and Chemical Toxicology24, 457–463.
37.
LeightonJ., NassauerJ., and TchaoR. (1985). The chick embryo in toxicology: an alternative to the rabbit eye.Food and Chemical Toxicology23, 293–298.
38.
LuepkeN.P. (1985). Hen's egg chorio-allantoic membrane test for irritation potential.Food and Chemical Toxicology23, 287–291.
39.
BurtonA.B.G., YorkM., and LawrenceR.S. (1981). The in vitro assessment of severe eye irritants.Food and Chemical Toxicology19, 471–480.
40.
ShawA.J., BallsM., ClothierR.H., and BatemanN.D. (1991). Predicting ocular irritancy and recovery from injury using Madin-Darby canine kidney cells.Toxicology in Vitro5, 569–571.
41.
GettingsS.D., TealJ.J., BagleyD.M., DemetruliasJ.L., DiPasqualeL.C., HintzeK.L., RosenM.G., WeiseS.L., ChudkowskiM., MarenusK.D., PapeW.J.W., RoddyM., SchnetzingerR., SilberP.M., GlazaS.M., and KurtzP.J. (1991). The CTFA Evaluation of Alternatives Program. An evaluation of In vitro alternatives to the Draize primary eye irritation test. (Phase I) Hydroalcoholic formulations; (Part 2) data analysis and biological significance, in VitroToxicology4, 247–287.
42.
LordoR., and FederP. (1991). The CTFA Evaluation of Alternatives Program. Phase II: Oil-water emulsions. Preliminary results of data analysis, 67 pp. Columbus: Battelle.
43.
WalumE., BallsM., BianchiV., BlaauboerB., BolcsfoldiG., GuillouzoA., MooreG.A., OdlandL., ReinhardtC., and SpielmannH. (1992). ECITTS: an integrated approach to the application of in vitro test systems to the hazard assessment of chemicals.ATLA, 20, 406–428.
44.
WalumE., and PetersenA. (1984). On the application of cultured neuroblastoma cells in chemical toxicity screening.Journal of Toxicology and Environmental Health13, 511–520.
45.
BallsM. (1992). The validation and acceptance of in vitro toxicity tests. In In Vitro Methods in Toxicology (ed. JollesG.), pp. 511–519. London: Academic Press.
46.
van den HeuvelM.J. (1990). A fixed-dose procedure as a replacement for the classical LD50 test: the UK initiative. In LD50 Testing and Classification Schemes: The Possibilities for Change, pp. 71–82. Brussels: CEC.
47.
BallsM., and ClothierR. (1987). Validation of alternative toxicity test systems: lessons learned and to be learned.Molecular Toxicology1, 547–559.
48.
Anon. (1991). Collaborative study on the evaluation of alternative methods to the eye irritation test. 54 + 296 pp. Doc. XI/632/91 — V/E/1/131/91. Brussels: CEC.
49.
SmithL.M., ClothierR.H., HillidgeS., and BallsM. (1992). Modification of the FRAME kenacid blue method for cytotoxicity tests on volatile materials.ATLA20, 230–234.
50.
ChamberlainM., and ParishW.E. (1990). Hazard and risk based on in vitro test data.Toxicology in Vitro4, 694–697.
